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disorders: 0.1263, 0.2265, 0.02604, 0.0136; (Log) Number of previous fractures: 
0.02572, 0.004297, 0.04713, 0.0186; (Log) Age: 0.07413, 0.008808, 0.1394, 0.0261; 
Ongoing congestive: 0.06264, 0.006147, 0.1191, 0.0298 for Parameter Estimate, 
Lower 95% CI, Upper 95% CI, P value, respectively. *Cohort p  0.0001 Deﬁned by 
OPAG. Investigator site included as a random effect.
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ASSESSMENT OF THE QUALITY OF LIFE IN WOMEN WITH  
VENOUS DISEASE
Taieb C
PFSA, Boulogne, France
Venous disease (VD) is characterized by an impairment of the ﬂaps or small valves, 
Currently, VD constitutes a real medical problem as well as a real socio-professional 
disability because of its physical symptoms. The quality of life (qol) of the patients is 
affected by this problem. OBJECTIVES: Assess, in real-life conditions, the impact of 
a Vitamin C, Ruscus and hesperidin methyl-chalcone based treatment, on the quality 
of life of patients with venous disease. METHODS: Pragmatic assessment in real-life 
conditions over a 7-day period with the pharmacist handing out the questionnaire 
when the treatment is delivered. The SQOR-V, a validated questionnaire available in 
several languages, was used. RESULTS: A total of 76 women were included, average 
age 48.95, average weight 63.5 kg with an average BMI of 23.8, 29% with a BMI 
higher than 25 and 79% are non smoking and 38% exercise regularly. 49% have a 
professional activity, of which 51% are required to stand for more than 6 hrs, and 
20% say they must stand without any rest. One patient in 3 believes that her discom-
fort (36%), complaints (36%) and pain (34%) had improved as soon as the 3rd day. 
On the 7th day, 2 in 3 patients believed that their discomfort (59%), complaints (58%) 
and their pain (61%) had improved. Seventy-nine percent of the patients declared 
being satisﬁed and 74% would recommend this treatment. This data is conﬁrmed 
through the qol life assessment. In fact, the qol assessment questionnaire SQOR-V 
shows a score of 45.24 at the time of inclusion, which became 39.66 at the end of 
the 7-day treatment period. The qol improvement is statistically signiﬁcant (p  0.03) 
CONCLUSIONS: The treatment shows its effectiveness in 7 days through a statisti-
cally signiﬁcant improvement of qol. This subjective data is conﬁrmed by the patients’ 
satisfaction expressed through the renewal of the treatment and recommending it to 
people they know.
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OBJECTIVES: Changed morbidity patterns in many industrialised countries lead to 
new requirements concerning the health care process. In contrast to a complete cure 
and due to increasing multiple chronic conditions with longevity, the alleviation of 
complaints and thereby securing the health-related quality of life (HRQoL) is more 
and more in the focus of efforts. Aim of this study is to analyse the effects of multiple 
chronic conditions on HRQoL in elderly people (q70 years). METHODS: Based on 
data from the getABI cohort (PRISCUS), empirical analyses were conducted. To evalu-
ate HRQoL a representative sample of 2,120 older participants (76.29 o 4.48 years, 
46.3% male) from Germany provided information on their current health status and 
completed the EQ-5D and the SF-8-questionnaires. RESULTS: Findings show clearly, 
that the existence of multiple chronic conditions (and not the ageing alone) has nega-
tive effects on HRQoL (p  0.000). There is an inverse relationship between HRQoL 
and multimorbidity in the elderly. In comparison to mental dimensions (p  0.234), 
physical domains are affected signiﬁcantly stronger by an increasing number of dis-
eases (p  0.000). Particularly new cardiovascular and cerebrovascular diseases in the 
last two years, the long-term existence of peripheral arterial disease and dysfunctions 
of the musculoskeletal system result in severe losses of HRQoL. On the contrary, other 
chronic conditions (hypertension, diabetes, lipometabolic disorder) or events more 
than two years ago do not have signiﬁcant inﬂuence on HRQoL. CONCLUSIONS: 
A clear understanding of the impacts of speciﬁc morbidity patterns on HRQoL in 
elderly persons can help to ensure an extensive and comprehensive health care process 
and to optimise it in the patients´ sense. This optimised process should not separate 
between single diagnoses, but focus on the concurrence of multiple conditions.
PIH39
VALIDITY AND RELIABILITY OF QUALITY OF LIFE ENJOYMENT AND 
SATISFACTION QUESTIONNAIRE FOR TURKISH WOMEN
Malhan S1, Oksuz E1, Baytar S2, Tulunay FC3
1Baskent University, Ankara, Turkey, 2Baskent University, ankara, Turkey, 3Ankara University 
Medical School, Ankara, Turkey
OBJECTIVES: The aim of this study was to determine the reliability and validity of 
the Quality of Life Enjoyment and Satisfaction Questionnaire (QLESQ) for Turkish 
women. METHODS: The data were collected through sociodemograﬁc questionnaire, 
QLESQ and EuroQol. The scale, which was translated into English from Turkish, 
again translated back into English by two independent translators, was applied to 168 
female subjects. The females above 25 consisted of 85 housewives and 83 working 
women. The scale was applied to 74 females in the pretest phase. The EuroQol-5D 
was used for concurrent validity. The EuroQol-5D was used for concurrent validity. 
Cronbach’s Alfa was used to assess reliability, and factor analysis to assess dimen-
sionality. RESULTS: The internal consistency coefﬁcient (Cronbach’s alpha) of 
QLESQ was 0.93. Factor analysis of the scale revealed that it was composed of three 
factors with Eigenvalues 2, accounting for 62.0% of the total variance. All items of 
the Turkish QLESQ had a factor load ranging from 0.22 to 0.76 There was a strong 
relationship between QLESQ, and EuroQoL 5D. CONCLUSIONS: The QLESQ has 
good validity and reliability for Turkish women.
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OBJECTIVES: Willingness to pay (WTP) per quality-adjusted life year (QALY) has 
been suggested as the threshold of cost-effectiveness analysis (CEA) in evaluating 
health technology. This study is to estimate the WTP/QALY in Chinese patients with 
chronic prostatitis (CP). METHODS: A consecutive sample of CP outpatients who 
visited 306 Hospital of PLA in Beijing, China at the beginning of 2009 was recruited. 
Their health related utility was assessed through EQ-5D and SF-6D; and their health 
status with EQ-VAS and National Institutes of Health-Chronic Prostatitis Symptom 
Index. A closed-ended iterative bidding contingent valuation method was used to elicit 
WTP for a hypothetical perfect health. WTP/QALY was calculated with the utility 
and WTP value elicited in this study. Multiple linear regression model was run to 
identify the effect of factors on the magnitude of WTP/QALY. RESULTS: After 
informed consent, 178 CP patients participated in the study. Mean (SD) EQ-5D and 
SF-6D utility weights were comparable at 0.74 (0.13) and 0.75 (0.09) respectively. 
WTP/QALY were estimated at US$8197 with EQ-5D and US$7684 with SF-6D, 
which were much lower than the often-cited threshold of cost-effectiveness analysis. 
Compared with the threshold recommended by World Health Organization, which is 
1–3 times of gross domestic product per capita, WTP/QALY from this study were also 
at the lower bound. Working and unmarried Patients with higher household income 
were willing to pay more for a QALY. CONCLUSIONS: As the ﬁrst study to estimate 
the WTP/QALY in China, this study demonstrated that question for WTP in this study 
is acceptable and feasible in Chinese CP patients, and the method to calculate WTP/
QALY produced meaningful answers. The lower WTP/QALY compared with the 
often-cited threshold of CEA suggests that WTP/QALY elicited from patients may not 
provide insight into societal valuations of medical expenditures.
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OBJECTIVES: Benzodiazepine (BZD) treatment of prolonged periods and higher 
dosage is not recommended for the elderly. Because of free choice of physicians and 
the absence of gatekeepers in Taiwan, this study aimed to identify prescription patterns 
and expenditure for long-term BZD treatment in elderly outpatients, and examine 
factors associated with the prescription overlap. METHODS: This study used a sam-
pling database from the Bureau of National Health Insurance. Subjects were included 
if they were aged 65 or over and had received any BZD prescription in 2002. Received 
BZDs were divided into prescribed and overlapped quantities in terms of deﬁned daily 
doses (DDDs) and expenditure. Single long-term prescriber was deﬁned as receiving 
more than 180 supply days from one department. The logistic model and multivariate 
regression models were used to evaluate associations of factors with the prescription 
overlap and quantities of overlap, respectively. RESULTS: In 2002, 1705 out of 7561 
elderly individuals had received BZDs with more than 180 prescription-covered days. 
Prescription overlap represented 10% of both their DDDs and expenditure. There 
were 107 subjects who had no single long-term prescriber and 362 subjects with more 
than 30 prescription-overlap days. Men, mental illness(es), comorbidities, multiple 
prescribers with or without a single long-term prescriber, and higher prescribed dose 
were associated with an increased likelihood of prescription overlap. Increased age, 
depression, a single long-term prescriber with or without multiple prescribers, and 
increased prescribed dose were correlated with increased overlapped DDD and expen-
diture. CONCLUSIONS: Eighteen percent of the elderly with long-term BZD treat-
ment were not under the authority of a single prescriber, and the prescription overlap 
was highly concentrated in 21% of them. Multiple prescribers increased the probabil-
ity of prescription overlap. Individuals with a single long-term prescriber and multiple 
prescribers had a higher risk of prescription overlap, and higher overlapped BZD 
DDDs and expenditure.
